We found the promotor role of miR-133a-3p inhibitors on GC malignant behaviors was successfully reversed by GABARAPL1 siRNA and HCQ including the proliferation rates (Fig. 4f),clonogenicity (Fig. 5a,b),DNA synthesis (Fig. 5c) and metastasis properties (Fig. 5d). Here, GABARAPL1 is linked to gastric cancer.